The Effect of Nonsurgical Periodontal Therapy on HNP1-3 Level in Gingival Crevicular Fluid of Chronic Periodontitis Patients

Ainamo J, Bay I (1975) Problems and proposals for recording gingivitis and plaque. Int Dent J 25:229–235 Armitage GC (1999) Development of a classification system for periodontal diseases and conditions. Ann Periodontol 4:1–6 Armitage GC (2004) Analysis of gingival crevicular fluid and risk of progression of periodontitis. Periodontol 2000 34:109–119 Ashitani J, Mukae H, Hiratsuka T et al (2002) Elevated levels of α-defensins in plasma and BAL fluid of patients with active pulmonary tuberculosis. Chest 121:519–526 Biragyn A (2005) Defensins—non-antibiotic use for vaccine development. Curr Protein Pept Sci 6:53–60 Bowdish DME, Davidson DJ, Hancock REW (2005) A re-evaluation of the role of host defence peptides in mammalian immunity. Curr Protein Pept Sci 6:35–51 Brogden KA, Heidari M, Sacco RE et al (2003) Defensin-induced adaptive immunity in mice and its potential in preventing periodontal disease. Oral Microbiol Immunol 18:95–99 Dale BA, Frederics LP (2005) Antimicrobial peptides in the oral environment: expression and function in health and disease. Curr Issues Mol Biol 7:119–134 Dale BA, Kimball JR, Krisanaprakornkit S et al (2001) Localized antimicrobial peptide expression in human gingiva. J Periodont Res 36:285–294 Dennison DK, Van Dyke TE (1997) The acute inflammatory response and the role of phagocytic cells in periodontal health and disease. Periodontol 2000 14:54–78 Doss M, White MR, Tecle T et al (2010) Human defensins and LL-37 in mucosal immunity. J Leukoc Biol 87:79–92 Fang XM, Shu Q, Chen QX et al (2003) Differential expression of alpha- and beta-defensins in human peripheral blood. Eur J Clin Invest 33:82–87 Gera JF, Lichtenstein A (1991) Human neutrophil peptide defensins induce single strand DNA breaks in target cells. Cell Immunol 138:108–120 Gorr SU, Abdolhosseini M (2011) Antimicrobial peptides and periodontal disease. J Clin Periodontol 38(Suppl 11):126–141 Griffiths G (2003) Formation, collection and significance of gingival crevice fluid. Periodontol 2000 31:32–42 Güncü GN, Yilmaz D, Könönen E et al (2015) Salivary antimicrobial peptides in early detection of periodontitis. Front Cell Infect Microbiol 5:99 Gursoy UK, Könönen E, Luukkonen N et al (2013) Human neutrophil defensins and their effect on epithelial cells. J Periodontol 84:126–133 Haffajee AD, Socransky SS (2006) Introduction to microbial aspects of periodontal biofilm communities, development and treatment. Periodontol 2000 42:7–12 Ihi T, Nakazato M, Mukae H et al (1997) Elevated concentrations of human neutrophil peptides in plasma, blood, and body fluids from patients with infections. Clin Infect Dis 25:1134–1140 Ishikawa I, Baehni P (2004) Nonsurgical periodontal therapy—where do we stand now? Periodontol 2000 36:9–13 Isomoto H, Mukae H, Ishimoto H et al (2004) Elevated concentrations of α-defensins in gastric juice of patients with H. pylori infection. Am J Gastroenterol 99:1916–1923 Keskin M, Könönen E, Sӧderling E et al (2014) Increased proliferation and decreased membrane permeability as defense mechanisms of Fusobacterium nucleatum against human neutrophilic peptide-1. Anaerobe 30:35–40 Kinane DF, Demuth DR, Gorr SU et al (2007) Human variability in innate immunity. Periodontol 2000 45:14–34 Kolenbrander PE, Palmer RJ Jr, Rickard AH et al (2006) Bacterial interactions and successions during plaque development. Periodontol 2000 42:47–79 Komatsuzawa H, Ouhara K, Kawai T et al (2007) Susceptibility of periodontopathogenic and cariogenic bacteria to defensins and potential therapeutic use of defensins in oral diseases. Curr Pharm Des 13:3084–3095 Lamster IB, Ahlo JK (2007) Analysis of gingival crevicular fluid as applied to the diagnosis of oral and systemic diseases. Ann NY Acad Sci 1098:216–229 Lamster IB, Oshrain RL, Gordon JM (1986) Enzyme activity in human gingival crevicular fluid: considerations in data reporting based on analysis of individual crevicular sites. J Clin Periodontol 13:799–804 Lee SH, Jun HK, Lee HR et al (2010) Antibacterial and lipopolisaccharide (LPS)-neutralising activity of human cationic antimicrobial peptides against periodontopathogenes. Int J Antimicrob Agents 35:138–145 Lundy FT, Orr D, Shaw C et al (2005) Detection of individual human neutrophil alpha-defensins (human neutrophil peptides 1, 2 and 3) in unfractionated gingival crevicular fluid-a MALDI-MS approach. Mol Immunol 42:575–579 Mailhot JM, Potempa J, Stein SH et al (1998) A relationship between proteinase activity and clinical parameters in the treatment of periodontal disease. J Clin Periodontol 25:578–584 McCormick TS, Weinberg A (2010) Epithelial cell-derived antimicrobial peptides are multifunctional agents that bridge innate and adaptive immunity. Periodontol 2000 54:195–206 McKay MS, Olson E, Hesla MA et al (1999) Immunomagnetic recovery of human neutrophil defensins from the human gingival crevice. Oral Microbiol Immunol 14:190–193 Miyasaki KT, Bodeau AL, Ganz T et al (1990) In vitro sensitivity of oral, gram negative, facultative bacteria to bactericidal activity of human neutrophil defensins. Infect Immun 58:3934–3940 Mizukawa N, Sugiyama K, Ueno T et al (1999) Levels of human defensin-1, an antimicrobial peptide, in saliva of patients with oral inflammation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 87:539–543 Musrati AA, Tervahartiala T, Gürsoy M et al (2016) Human neutrophil peptide-1 affects matrix metaloproteinase-2, -8 and -9 secretions of oral squamous cell carcinoma cell lines in vitro. Arch Oral Biol 66:1–7 Nishihara T, Koseki T (2004) Microbial etiology of periodontitis. Periodontol 2000 36:14–26 Nussbaum G, Shapira L (2011) How has neutrophil research improved our understanding of periodontal pathogenesis? J Clin Periodontol 38(Suppl. 11):49–59 Otvos L (2005) Antibacterial peptides and proteins with multiple cellular targets. J Peptide Sci 11:697–706 Paster BJ, Olsen I, Aas JA et al (2006) The breadth of bacterial diversity in the human periodontal pocket and other oral sites. Periodontol 2000 42:80–87 Peschel A (2002) How do bacteria resist human antibacterial peptides? Trends Microbiol 10:179–186 Puklo M, Guentsch A, Hiemstra PS et al (2008) Analysis of neutrophil-derived antimicrobial peptides in gingival crevicular fluid suggests importance of cathelicidin LL-37 in the innate immune response against periodontogenic bacteria. Oral Microbiol Immunol 23:328–335 Rangé H, Léger T, Huchon C et al (2012) Salivary proteome modifications associated with periodontitis in obese patients. J Clin Periodontol 39:799–806 Silness J, Löe HP (1964) Periodontal disease in pregnacy. II Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 22:121–135 Silva MP, Feres M, Sirotto TA et al (2011) Clinical and microbiological benefits of metronidazole alone or with amoxicillin as adjuncts in the treatment of chronic periodontitis: a randomized placebo-controlled clinical trial. J Clin Periodontol 38:828–837 Socransky SS, Haffajee AD (2005) Periodontal microbial ecology. Periodontol 2000 38:135–187 Türkoğlu O, Emingil G, Kütükcüler N et al (2010) Evaluation of gingival crevicular fluid adrenomedullin and human neutrophil peptide 1–3 levels of patients with different periodontal diseases. J Periodontol 81:284–291 van Winkelhoff AJ, Rodenburg JP, Goené RJ et al (1989) Metronidazole plus amoxycillin in the treatment of Actinobacillus associated periodontitis. J Clin Periodontol 16:128–131 Winkel EG, Van Winkelhoff AJ, Timmerman MF et al (2001) Amoxicillin plus metronidazole in the treatment of adult periodontitis patients. A double-blind placebo-controlled study. J Clin Periodontol 28:296–305